Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2017 call → NOWe need answer only YES or NO based on transcript. Need determine if management describes successive engagements of same kind coming in at progressively larger size. Need look for evidence. Transcript: partnerships with J&J, hospital systems, payers. Need see if management conveys that deals/programs now individually bigger/broader/longer than before. Examples: J&J partnership? They mention PEAK programs six-fold increase in number, not size. Account activation growing. New collaborations: WellStar, ISQIC, CTCA, UT. Are these larger than previous? Not necessarily. They say "growing number of key organizations" not size. "We continue to have discussions with additional likeminded partners" not size. "Our collaboration with J&J continues to advance" but no mention of larger deals. "Trinity" relationship brought other health systems. No explicit escalation of unit size. They mention "Aetna" expanding beyond oral maxillofacial surgery? That could be broader scope? Let's examine. Dave: "we are working with Aetna to expand that opportunity beyond oral maxillofacial surgery." That is expanding scope of collaboration? But is that "successive engagements of same kind coming in at progressively larger size"? It's same partner expanding, not new deals larger. Also "Aetna leads the way but there are a number of other Aetna-like relationships at various stages" not necessarily larger. Question asks: "does management convey that the deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago" Need YES if management's own words convey one coherent phenomenon as present-tense reality: unit size of repeatable business escalating. Need comparison against own recent past, already real and recurring, early. Look for phrases: "new collaborations" maybe "Cancer Treatment Centers of America" etc. But no mention of size. "J&J has committed to resourcing a six-fold increase in the number of PEAK programs in 2018." That's volume, not size. "number of activated accounts continued to grow" volume. "In just one year, we have created an energy..." no. Maybe "our partnership with J&J continues to gain traction and helped accelerate EXPAREL daily growth to 10%" no. "Securing separate reimbursement for EXPAREL would create a significant opportunity" not yet.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.